Effects of DNA methyltransferase 1 inhibition on esophageal squamous cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Esophageal squamous cell carcinoma (ESCC) is a significant global health concern.
• Aberrant DNA methylation is implicated in cancer development, with DNA methyltransferase 1 (DNMT1) playing a key role.
• Understanding DNMT1's role in ESCC is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the expression levels of DNMT1 in ESCC tissues.
• To evaluate the therapeutic potential of DNMT1-targeted small interfering RNA (siRNA) in ESCC.
• To elucidate the molecular mechanisms underlying DNMT1's function in ESCC.

Main Methods:

• Quantitative analysis of DNMT1 messenger RNA (mRNA) and protein expression in ESCC samples.
• RNA interference (RNAi) was used to knockdown DNMT1 in the human ESCC cell line KYSE30.
• Assessment of cell proliferation, viability, apoptosis, and promoter methylation status following DNMT1 knockdown.

Main Results:

• DNMT1 mRNA was overexpressed in a majority of ESCC samples compared to non-cancerous tissues.
• DNMT1 protein levels showed a correlation with lymph node metastasis in ESCC patients.
• DNMT1 knockdown in KYSE30 cells led to reduced promoter methylation, re-expression of tumor suppressor genes (e.g., methyl-guanine methyl-transferase, retinoic acid receptors beta), inhibited cell proliferation/viability, and induced apoptosis.

Conclusions:

• DNMT1 overexpression is a common event in ESCC and is associated with lymph node metastasis.
• Targeting DNMT1 using RNA interference demonstrates therapeutic potential by reversing epigenetic dysregulation and inhibiting tumor progression.
• DNMT1 knockdown offers a promising strategy for ESCC treatment by reactivating tumor suppressor genes and inducing cancer cell death.